Epilepsy and Cannabis

In a survey of parents using cannabidiol (CBD)-enriched cannabis as a treatment for children with treatment-resistant epilepsy, a high rate of success in reducing seizure frequency was reported. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
Porter BE, Jacobson C.
Epilepsy Behav. 2013 Dec;29(3):574-7.
doi: 10.1016/j.yebeh.2013.08.037.
PubMed PMID: 24237632; PubMed Central PMCID: PMC4157067.

A CBD based medicine developed by GW Pharmacueticals is being trialled in the USA.

Epidiolex® has been given orphan drug status by the FDA for Lennox-Gastaut Syndrome. GW Pharmaceuticals.
Press release: 28 February 2014
URL: GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex® in the Treatment of Lennox-Gastaut Syndrome. Fast track designation has also been given by the FDA for Dravet Syndrome. GW Pharmaceuticals.
Press release: 6 June 2014
URL: GW Pharmaceuticals Announces Epidiolex® Receives Fast Track Designation from FDA for the Treatment of Dravet Syndrome.

Further reading

GW Pharmacueticals: Epidiolex

Articles and editorials

WIRED - July 2015.
BOY INTERRUPTED - One Man's Desperate Quest to Cure His Son's Epilepsy - With Weed.

Courier Mail - July 2015.
Ipswich families are waiting for medicinal marijuana trials to begin, living every day with seizures and chronic pain

The Chronicle - July 2015
Medical cannabis is helping save my son's life